![]() |
市場調查報告書
商品編碼
1738457
血流量計市場按產品類型、應用、最終用戶和地區分類Blood Flow Measurement Devices Market, By Product Type, By Application, By End User, By Geography |
血流測量設備市場規模預計在 2025 年達到 8.86 億美元,預計到 2032 年將達到 16.521 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 9.3%。
報告範圍 | 報告詳細資訊 | ||
---|---|---|---|
基準年 | 2024 | 2025年的市場規模 | 8.86億美元 |
效能數據 | 2020-2024 | 預測期 | 2025-2032 |
預測期:2025-2032年複合年成長率: | 9.30% | 2032年價值預測 | 16.521億美元 |
過去幾年,由於全球心血管疾病的發生率不斷上升,全球血流測量設備市場發展迅速。患有心臟衰竭、冠狀動脈疾病等心臟病的患者數量不斷增加,推動了對有助於準確診斷的先進血流測量設備的需求。醫療設備業的技術不斷進步,推動了非侵入性和微創血流測量解決方案的發展。數位化醫療的普及和人工智慧的融合進一步完善了血流分析。據報道,目前正在進行的旨在開發可靠且價格合理的血流監測系統的研究將有助於市場在2030年前實現擴張。
全球範圍內,患有慢性心臟疾病的老年人口不斷增加,是主要的成長動力。根據世界衛生組織統計,心血管疾病每年導致超過1700萬人死亡,佔全球死亡總數的三分之一。這促使各國政府增加公共醫療支出,進而使市場參與者受益。然而,技術先進的血流測量設備價格昂貴,這在一定程度上阻礙了其廣泛普及,尤其對於低收入國家的患者而言。另一方面,持續研發適用於資源匱乏環境的經濟高效產品,正為新興經濟體開闢新的商機。公共和私營部門對醫療技術開發的投資不斷增加,預計將進一步推動市場需求。
本報告對全球血流測量設備市場進行了詳細分析,並以 2024 年為基準年,給出了預測期(2025-2032 年)的市場規模和年複合成長率(CAGR%)。
它強調了各個領域的潛在商機,並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球血流計量設備市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
本研究報告中介紹的主要企業包括 Cook Medical Inc.、Medistim ASA、Transonic Systems Inc.、Deltex Medical Group PLC、Atys Medical、Getinge Group、Perimed AB、Compumedics、ADInstruments、Moor Instruments Ltd.、SONOTEC GmbH、ArjoHuntleigh Inc.、Cheetah Medical、Biopakxing. Biomedical、Koven Technology、GSI Group 和 Nihon Kohden Corporation。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球血流測量設備市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
可以透過用於分析全球血流量計設備市場的各種策略矩陣來促進相關人員的決策。
Blood Flow Measurement Devices Market is estimated to be valued at USD 886.0 Mn in 2025 and is expected to reach USD 1,652.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 886.0 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 9.30% | 2032 Value Projection: | USD 1,652.1 Mn |
The global blood flow measurement devices market has been gaining significant traction over the past couple of years owing to growing prevalence of cardiovascular diseases worldwide. Rising number of patients suffering from heart conditions like heart failure, coronary artery disease etc has boosted demand for advanced blood flow measurement devices that helps achieve accurate diagnosis. Constant technological advancements in medical devices industry has led to development of non-invasive and minimally-invasive blood flow measurement solutions. Adoption of digital healthcare and integration of artificial intelligence further complements the blood flow analysis. Continuous research activities to develop reliable and affordable blood flow monitoring systems will reportedly aid the market expansion through 2030.
Growing geriatric population base suffering from chronic heart diseases around the globe acts as a key growth driver. According to WHO, cardiovascular illnesses account for over 17 million yearly deaths representing one third of all global deaths. This has prompted governments to increase public healthcare spending which benefits market players. However, expensive price tags of technologically sophisticated blood flow measurement devices especially for patients in low-income nations continues to deter their widespread adoption to some extent. On the brighter side, ongoing R&D to create cost-effective product variants suitable for resource-poor setups provides new opportunities in emerging countries. Rising investments by both public and private sectors in medical technology development is anticipated to further fuel the market demand.
This report provides in-depth analysis of the global blood flow measurement devices market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood flow measurement devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Cook Medical Inc., Medistim ASA, Transonic Systems Inc., Deltex Medical Group PLC, Atys Medical, Getinge Group, Perimed AB, Compumedics, ADInstruments, Moor Instruments Ltd., SONOTEC GmbH, ArjoHuntleigh Inc., Cheetah Medical, Biopac Systems Inc., D.E. Hokie & Associates, NDS Surgical Imaging, Fluke Biomedical, Koven Technology, GSI Group, and Nihon Kohden Corporation are the major players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood flow measurement devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood flow measurement devices market.
Detailed Segmentation-